ADVANCED PHARMACOLOGY FOR
g g gg
PRESCRIBERS 1ST EDITION BY LUO K
g g g g g
AYINGO TEST BANK | 2024 UPDATE
g g g g g
, Table of Contents
g g
Chapterg 1:gAngIntroductiongtogEvidence-BasedgClinicalg PracticegGuidelines ............................................... 3
Chapterg 2:gPharmacokineticsg /Chapter3:g Pharmacodynamics ..................................................................... 13
Chapter4:gPharmacogeneticsg andgPharmacogenomics................................................................................. 25
Chapterg 5:gPharmacologyg AcrossgthegLifegSpan .......................................................................................... 30
Chapterg 6:gDrug-TherapygPrescribinggingSpecialgPopulations ..................................................................... 36
Chapterg 7:gDruggDevelopmentg andgApproval .............................................................................................. 45
Chapterg8-Chapterg10:gFoundationsgofgPrescriptiongWritinggChapterg9:gResponsibleControlled-
SubstancegPrescribinggChapterg10:gAntibioticgStewardship ......................................................................... 51
Chapterg 11:g AppliedgCalculationsg forg Prescribing....................................................................................... 58
Chapterg12-:gPromotinggAdherencegWithgPharmacotherapygII:gSystem-SpecificgandgPatient-
FocusedgPrescribinggChapterg13:gPharmacotherapygforgEar,gNose,gMouth,gandThroatgConditionsg/Chapterg1
4:gPharmacotherapygforgEyegConditions ...................................................................................................... 67
Chapterg 15:gPharmacotherapygforg Sking Conditions ..................................................................................... 74
Chapterg 16:gPharmacotherapyg forg Neurologicg Conditions .......................................................................... 81
Chapterg 17:gPharmacotherapygforg Cardiovascularg Conditions .................................................................... 94
Chapterg 18:gPharmacotherapygforg RespiratorygConditions........................................................................ 106
Chapterg19:gPharmacotherapygforgGastrointestinalgConditionsgandgConditionsgRequiringNutritionalgSuppor
t .................................................................................................................................................................. 117
Chapterg 20:gPharmacotherapygforg GenitourinarygConditions .................................................................... 128
Chapterg21:gPharmacotherapygforg Renal,gAcid–Base,g Fluid,gandgElectrolytegDisorders ........................... 133
Chapterg 22:gPharmacotherapyg forg Musculoskeletalgandg Rheumatologicg Conditions ................................ 146
Chapterg 23:gTherapeuticg Applicationsg ofg Immunologyg andg Vaccines ...................................................... 158
Chapterg 24:gPharmacotherapyg forg EndocrinegDisorders ............................................................................ 163
Chapterg 25:gPharmacotherapygforgHematologicg Disorders ........................................................................ 174
Chapterg 26:gHematology/OncologygandgSupportiveg Caregforg thegNononcologist ..................................... 190
Chapterg 27:gPharmacotherapyg RelatedgtogWomen’sg Healthg Conditions ................................................... 196
Chapterg 28:gPharmacotherapygRelatedgtogMen’sg Healthg Conditions ......................................................... 211
Chapterg 29:gPharmacotherapyg Relatedg togTransgenderg Care .................................................................... 217
Chapterg 30:gAntimicrobialgPharmacotherapy ............................................................................................ 224
Chapterg 31:gAntiretroviralgPharmacotherapy ............................................................................................. 235
Chapterg32:gPsychopharmacologygandgIntegrativegHealth:gCombinedgTreatmentgofPsychiatricgandgNeuroco
gnitiveg Conditions ...................................................................................................................................... 247
Chapterg 33:gPharmacotherapygforg PaingManagement ................................................................................ 257
Chapterg 34:gSubstancegUsegDisorderg III:gHealthgPromotiongandgMaintenance.......................................... 267
Chapterg 35:gOver-the-Counterg Medications .............................................................................................. 283
Chapterg 36:gPharmacotherapygforg Obesity ................................................................................................ 291
,Chapterg1:gAngIntroductiongtogEvidence-BasedgClinicalgPracticegGuidelines
MULTIPLEgCHOICE
• Whatgisgthegprimaryg purposeg ofgtheg nursingg assessment?
A. Identifyingg underlyingg pathologicg conditions
B. Assistingg theg physiciang ingidentifyingg medicalg conditions
C. Determiningg theg patientsgmentalgstatus
D. Exploringg patientg responsesg tog healthg problems
ANS:gD
Agnursinggassessmentgisgdonegtogidentifygthegpatientsgresponsegtoghealthgpro
blems.gDuringgthegnursinggassessmentgphase,gagcomprehensiveginformationg
basegisgdevelopedgthroughgagphysicalgexamination,gnursingghistory,gmedicati
onghistory,gandgprofessionalgobservation.gIdentifyinggunderlyinggpathologicg
conditionsgandgassistinggthegphysiciangingidentifyinggmedicalgconditionsgisgn
otgpartgofgthegnursinggprocess.gDetermininggthegpatientsg mentalgstatusg isgone
gpartg ofgtheg nursingg assessment,g butg itg isg notgthegprimarygpurpose.
DIF:gCognitivegLevel:gComprehensiong
REF:gdmg36gOBJ:g1g|g3gTOP:gNursinggP
rocessgStep:gAssessment
MSC:gNCLEXg Clientg Needsg Category:g HealthgPromotiong andg Maintenance
• Whatgisgthegbasisg ofgthegNANDAgIg taxonomy?
A. Functionalg healthgpatterns
B. Humangresponseg patterns
C. Basicg humang needs
D. Pathophysiologicg needs
ANS:gB
Theg NANDAg Ig taxonomyg identifiesg humang responseg patterns.gFunction
algcomponentsgofghealthgpatternsgareglimitedgtogactivity,gfluidgvolume,gnutri
tion,gselfgcare,gandgsensorygperception.gBasicghumangneedsgcompriseglessgt
hangmerelyghealthgpatterns.g Pathophysiologicgneedsg aregnotgpartgofgthegsco
pegofgNANDAgI.
, DIF:gCognitivegLevel:gKnowledgegREF
:gpp.g37-38gOBJ:g5gTOP:
NursinggProcessgStep:gDiagnosis
MSC:gNCLEXg Clientg Needsg Category:g Physiologicalg Integrity
• Whichgtaskgisgincludedg ingthegassessmentg stepg ofgthegnursingg process?
A. Establishingg patientg goals/outcomes
B. Implementingg theg nursingg careg plang (NCP)
C. Measuringg goal/outcomeg achievement
D. Collectingg andg communicatingg data
ANS:gD
Datagaregcollectedgandgcommunicatedgingthegassessmentgphasegofgthegnursin
ggprocess.gEstablishingggoalsgisgthegfunctiongofgplanning.
ImplementinggthegNCPgisgthegfunctiongofgimplementation.gMeasuringgoutco
megachievementgisgthegfunctiongofgevaluation.
DIF:gCognitivegLevel:gComprehensiong
REF:gdmg36gOBJ:g2g|g3gTOP:gNursinggP
rocessgStep:gAssessment
MSC:gNCLEXg Clientg Needsg Category:g HealthgPromotiong andg Maintenance
• Whichgstatementg regardingg nursingg diagnosesg isg accurate?
a. Nursingg diagnosesgremaingthegsameg forgasg longgasgthegdiseaseg isg present.
b. Nursingg diagnosesg areg writteng tog identifygdiseasegstates.
c. Nursingg diagnosesg describeg patientg problemsg thatg nursesg treat.
d. Nursingg diagnosesg identifygcausesg relatedg togillness.
ANS:gC
Diagnosticgstatementsgidentifygproblemsgagnursegisgindependentlygablegtogtr
eatgwithingthegscopegofgprofessionalgpractice.gNursinggdiagnosesgvarygwithgt
hegchanginggconditiongofgthegpatient.gThegresponsegpatternsgareguniquegtogth
egpatientgandgaregnotgdiseasegspecific.gNursinggdiagnosesgdescribegthegpatie
ntsghumangresponsegpattern.
DIF:g Cognitiveg Level:g Comprehension
g g gg
PRESCRIBERS 1ST EDITION BY LUO K
g g g g g
AYINGO TEST BANK | 2024 UPDATE
g g g g g
, Table of Contents
g g
Chapterg 1:gAngIntroductiongtogEvidence-BasedgClinicalg PracticegGuidelines ............................................... 3
Chapterg 2:gPharmacokineticsg /Chapter3:g Pharmacodynamics ..................................................................... 13
Chapter4:gPharmacogeneticsg andgPharmacogenomics................................................................................. 25
Chapterg 5:gPharmacologyg AcrossgthegLifegSpan .......................................................................................... 30
Chapterg 6:gDrug-TherapygPrescribinggingSpecialgPopulations ..................................................................... 36
Chapterg 7:gDruggDevelopmentg andgApproval .............................................................................................. 45
Chapterg8-Chapterg10:gFoundationsgofgPrescriptiongWritinggChapterg9:gResponsibleControlled-
SubstancegPrescribinggChapterg10:gAntibioticgStewardship ......................................................................... 51
Chapterg 11:g AppliedgCalculationsg forg Prescribing....................................................................................... 58
Chapterg12-:gPromotinggAdherencegWithgPharmacotherapygII:gSystem-SpecificgandgPatient-
FocusedgPrescribinggChapterg13:gPharmacotherapygforgEar,gNose,gMouth,gandThroatgConditionsg/Chapterg1
4:gPharmacotherapygforgEyegConditions ...................................................................................................... 67
Chapterg 15:gPharmacotherapygforg Sking Conditions ..................................................................................... 74
Chapterg 16:gPharmacotherapyg forg Neurologicg Conditions .......................................................................... 81
Chapterg 17:gPharmacotherapygforg Cardiovascularg Conditions .................................................................... 94
Chapterg 18:gPharmacotherapygforg RespiratorygConditions........................................................................ 106
Chapterg19:gPharmacotherapygforgGastrointestinalgConditionsgandgConditionsgRequiringNutritionalgSuppor
t .................................................................................................................................................................. 117
Chapterg 20:gPharmacotherapygforg GenitourinarygConditions .................................................................... 128
Chapterg21:gPharmacotherapygforg Renal,gAcid–Base,g Fluid,gandgElectrolytegDisorders ........................... 133
Chapterg 22:gPharmacotherapyg forg Musculoskeletalgandg Rheumatologicg Conditions ................................ 146
Chapterg 23:gTherapeuticg Applicationsg ofg Immunologyg andg Vaccines ...................................................... 158
Chapterg 24:gPharmacotherapyg forg EndocrinegDisorders ............................................................................ 163
Chapterg 25:gPharmacotherapygforgHematologicg Disorders ........................................................................ 174
Chapterg 26:gHematology/OncologygandgSupportiveg Caregforg thegNononcologist ..................................... 190
Chapterg 27:gPharmacotherapyg RelatedgtogWomen’sg Healthg Conditions ................................................... 196
Chapterg 28:gPharmacotherapygRelatedgtogMen’sg Healthg Conditions ......................................................... 211
Chapterg 29:gPharmacotherapyg Relatedg togTransgenderg Care .................................................................... 217
Chapterg 30:gAntimicrobialgPharmacotherapy ............................................................................................ 224
Chapterg 31:gAntiretroviralgPharmacotherapy ............................................................................................. 235
Chapterg32:gPsychopharmacologygandgIntegrativegHealth:gCombinedgTreatmentgofPsychiatricgandgNeuroco
gnitiveg Conditions ...................................................................................................................................... 247
Chapterg 33:gPharmacotherapygforg PaingManagement ................................................................................ 257
Chapterg 34:gSubstancegUsegDisorderg III:gHealthgPromotiongandgMaintenance.......................................... 267
Chapterg 35:gOver-the-Counterg Medications .............................................................................................. 283
Chapterg 36:gPharmacotherapygforg Obesity ................................................................................................ 291
,Chapterg1:gAngIntroductiongtogEvidence-BasedgClinicalgPracticegGuidelines
MULTIPLEgCHOICE
• Whatgisgthegprimaryg purposeg ofgtheg nursingg assessment?
A. Identifyingg underlyingg pathologicg conditions
B. Assistingg theg physiciang ingidentifyingg medicalg conditions
C. Determiningg theg patientsgmentalgstatus
D. Exploringg patientg responsesg tog healthg problems
ANS:gD
Agnursinggassessmentgisgdonegtogidentifygthegpatientsgresponsegtoghealthgpro
blems.gDuringgthegnursinggassessmentgphase,gagcomprehensiveginformationg
basegisgdevelopedgthroughgagphysicalgexamination,gnursingghistory,gmedicati
onghistory,gandgprofessionalgobservation.gIdentifyinggunderlyinggpathologicg
conditionsgandgassistinggthegphysiciangingidentifyinggmedicalgconditionsgisgn
otgpartgofgthegnursinggprocess.gDetermininggthegpatientsg mentalgstatusg isgone
gpartg ofgtheg nursingg assessment,g butg itg isg notgthegprimarygpurpose.
DIF:gCognitivegLevel:gComprehensiong
REF:gdmg36gOBJ:g1g|g3gTOP:gNursinggP
rocessgStep:gAssessment
MSC:gNCLEXg Clientg Needsg Category:g HealthgPromotiong andg Maintenance
• Whatgisgthegbasisg ofgthegNANDAgIg taxonomy?
A. Functionalg healthgpatterns
B. Humangresponseg patterns
C. Basicg humang needs
D. Pathophysiologicg needs
ANS:gB
Theg NANDAg Ig taxonomyg identifiesg humang responseg patterns.gFunction
algcomponentsgofghealthgpatternsgareglimitedgtogactivity,gfluidgvolume,gnutri
tion,gselfgcare,gandgsensorygperception.gBasicghumangneedsgcompriseglessgt
hangmerelyghealthgpatterns.g Pathophysiologicgneedsg aregnotgpartgofgthegsco
pegofgNANDAgI.
, DIF:gCognitivegLevel:gKnowledgegREF
:gpp.g37-38gOBJ:g5gTOP:
NursinggProcessgStep:gDiagnosis
MSC:gNCLEXg Clientg Needsg Category:g Physiologicalg Integrity
• Whichgtaskgisgincludedg ingthegassessmentg stepg ofgthegnursingg process?
A. Establishingg patientg goals/outcomes
B. Implementingg theg nursingg careg plang (NCP)
C. Measuringg goal/outcomeg achievement
D. Collectingg andg communicatingg data
ANS:gD
Datagaregcollectedgandgcommunicatedgingthegassessmentgphasegofgthegnursin
ggprocess.gEstablishingggoalsgisgthegfunctiongofgplanning.
ImplementinggthegNCPgisgthegfunctiongofgimplementation.gMeasuringgoutco
megachievementgisgthegfunctiongofgevaluation.
DIF:gCognitivegLevel:gComprehensiong
REF:gdmg36gOBJ:g2g|g3gTOP:gNursinggP
rocessgStep:gAssessment
MSC:gNCLEXg Clientg Needsg Category:g HealthgPromotiong andg Maintenance
• Whichgstatementg regardingg nursingg diagnosesg isg accurate?
a. Nursingg diagnosesgremaingthegsameg forgasg longgasgthegdiseaseg isg present.
b. Nursingg diagnosesg areg writteng tog identifygdiseasegstates.
c. Nursingg diagnosesg describeg patientg problemsg thatg nursesg treat.
d. Nursingg diagnosesg identifygcausesg relatedg togillness.
ANS:gC
Diagnosticgstatementsgidentifygproblemsgagnursegisgindependentlygablegtogtr
eatgwithingthegscopegofgprofessionalgpractice.gNursinggdiagnosesgvarygwithgt
hegchanginggconditiongofgthegpatient.gThegresponsegpatternsgareguniquegtogth
egpatientgandgaregnotgdiseasegspecific.gNursinggdiagnosesgdescribegthegpatie
ntsghumangresponsegpattern.
DIF:g Cognitiveg Level:g Comprehension